X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development
NCT ID: NCT00965679
Last Updated: 2017-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1 participants
OBSERVATIONAL
2009-08-06
2010-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Computed tomography (CT) creates three-dimensional images based on X-ray imaging. CT is useful for determining treatment approaches for certain diseases, such as calcific aortic stenosis (narrowing of the aorta because of calcium deposits).
* Comparing the data received from CT scans with the data received from heart catheterization (which assesses the heart's condition and function) can be used to improve treatment in patients with certain heart conditions. Researchers are interested in looking at the effectiveness of both procedures in assessing possible surgical treatments for patients with calcific aortic stenosis.
Objectives:
\- To analyze cardiac CT scans in conjunction with existing heart scan results to improve treatments for future minimally invasive aortic valve replacement.
Eligibility:
\- Patients 18 years of age and older who have been diagnosed with aortic valve stenosis that may be treated surgically, and who will undergo or have recently undergone heart catheterization.
Design:
* Participants will have a CT scan within 90 days of the medically necessary heart catheterization, but before any other surgical or catheter treatment.
* During the CT scan, patients will be asked to hold their breath intermittently for about 5 to 20 seconds. Patients will be inside the scanner for less than 30 minutes.
* Patients will be asked to return in 3 to 7 days for a blood test to check kidney function.
* Researchers will analyze the results of the CT scan in conjunction with the previous results from the catheterization to determine possible improved treatment options.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography
NCT01757678
Study of Coronary Artery Disease by Two Types of Angiography
NCT00273819
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT01621594
Visual Estimation of Coronary Fractional Flow Reserve From High-definition Computed Tomographic Coronary Angiography
NCT02179957
Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
NCT02007967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients age 18 years or older
* Having calcific aortic stenosis being considered for surgical or catheter-based treatment, determined on physical examination or noninvasive imaging such as echocardiography
* Undergoing diagnostic cardiac catheterization within 1 year
* Able to provide informed consent
ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
* Adult patients age 18 years or older
* Having calcific aortic stenosis being considered for surgical or catheter-based treatment, determined on physical examination or noninvasive imaging such as echocardiography
* Undergoing diagnostic cardiac catheterization within 1 year
* Having undergone cardiac CT for medical indications meeting the technical requirements of this protocol
* Able to provide informed consent
Exclusion Criteria
* Pregnant or lactating women
* Decompensated heart failure (unable to lie flat during CT)
* Advanced atrioventricular block (Mobitz Type II second degree or third degree atrioventricular heart block)
* Asthma or chronic obstructive pulmonary disease (emphysema) currently treated with beta adrenergic agonists
-Severe kidney disease (MDRD estimated Glomerular Filtration Rate
\< 30mL/min/l.73m(2)).
-Request of referring physician or surgeon not to administer iodinated radiocontrast
ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
-None
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gutierrez LF, Silva Rd, Ozturk C, Sonmez M, Stine AM, Raval AN, Raman VK, Sachdev V, Aviles RJ, Waclawiw MA, McVeigh ER, Lederman RJ. Technology preview: X-ray fused with magnetic resonance during invasive cardiovascular procedures. Catheter Cardiovasc Interv. 2007 Nov 15;70(6):773-82. doi: 10.1002/ccd.21352.
Phan A, Dalle S, Thomas L. [Acquired pigmented lesion of the finger pulp]. Ann Dermatol Venereol. 2009 May;136(5):477-8. doi: 10.1016/j.annder.2008.09.020. Epub 2009 Mar 10. No abstract available. French.
Tenaza RR. Songs, choruses and countersinging of Kloss' gibbons (Hylobates klossii) in Siberut Island, Indonesia. Z Tierpsychol. 1976 Jan;40(1):37-52. doi: 10.1111/j.1439-0310.1976.tb00924.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-H-0211
Identifier Type: -
Identifier Source: secondary_id
090211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.